Jay Pundavela

5PUBLICATIONS
16CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseasesPeripheral nervous systemPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 02, 2026
KRAS is required for plexiform neurofibroma formation and represents a targetable vulnerability in established tumors.

|Mar 13, 2025
Granulocyte-Macrophage Colony Stimulating Factor Receptor Contributes to Plexiform Neurofibroma Initiation.

Jay Pundavela, Ashley Hall, Samantha Anne Dinglasan

|Oct 16, 2024
Stimulator of interferon gene facilitates recruitment of effector CD8 T cells that drive neurofibromatosis type 1 nerve tumor initiation and maintenance.

Jay Pundavela, Samantha Anne Dinglasan, Melissa Touvron

|Mar 08, 2024
C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis.

Melissa R Perrino, Niousha Ahmari, Ashley Hall

|Jun 03, 2021
WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth.

Craig S Thomson, Jay Pundavela, Melissa R Perrino

Pageof 1

Frequent Collaborators

5 joint publications

Nancy Ratner

2 joint publications

Eva Dombi

2 joint publications

Jianqiang Wu

1 joint publications

Craig S Thomson